Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 292

1.

Dialysis-associated hyperglycemia: manifestations and treatment.

Sun Y, Roumelioti ME, Ganta K, Glew RH, Gibb J, Vigil D, Do C, Servilla KS, Wagner B, Owen J, Rohrscheib M, Dorin RI, Murata GH, Tzamaloukas AH.

Int Urol Nephrol. 2020 Mar;52(3):505-517. doi: 10.1007/s11255-019-02373-1. Epub 2020 Jan 18. Review.

PMID:
31955362
2.

Serum Sodium Concentration and Tonicity in Hyperglycemic Crises: Major Influences and Treatment Implications.

Tzamaloukas AH, Khitan ZJ, Glew RH, Roumelioti ME, Rondon-Berrios H, Elisaf MS, Raj DS, Owen J, Sun Y, Siamopoulos KC, Rohrscheib M, Ing TS, Murata GH, Shapiro JI, Malhotra D.

J Am Heart Assoc. 2019 Oct;8(19):e011786. doi: 10.1161/JAHA.118.011786. Epub 2019 Sep 24. No abstract available.

3.

Management of plasma hypertonicity resulting from osmotic diuresis.

Roumelioti ME, Tzamaloukas AH.

Int Urol Nephrol. 2019 Jun;51(6):1079-1080. doi: 10.1007/s11255-019-02137-x. Epub 2019 May 16. No abstract available.

PMID:
31098817
4.

Symptomatic Hyperglycemia in a Patient with Dialysis Ascites.

Vigil D, Kien C, Gibb J, Glew RH, Tzamaloukas AH.

Am J Med Sci. 2019 Jun;357(6):512-516. doi: 10.1016/j.amjms.2019.02.016. Epub 2019 Feb 27. Review.

PMID:
30975430
5.

Tumoral Calcinosis of the Neck in a Patient with Systemic Sclerosis.

Logothetis CN, Emil NS, Tzamaloukas AH, Konstantinov KN.

Cureus. 2018 Nov 13;10(11):e3585. doi: 10.7759/cureus.3585.

6.

Noninfectious Cloudy Peritoneal Effluent in a Peritoneal Dialysis Patient with Mantle Cell Lymphoma.

Vigil D, Reyes MD, Polak S, Sun Y, Blacklock L, Tzamaloukas AH.

Cureus. 2018 Oct 4;10(10):e3413. doi: 10.7759/cureus.3413.

7.

Hyperglycemic Crisis in an Anuric Peritoneal Dialysis Patient with Profound and Symptomatic Hypertonicity.

Gibb J, Xu Z, Rohrscheib M, Tzamaloukas AH.

Cureus. 2018 May 2;10(5):e2566. doi: 10.7759/cureus.2566.

8.

Principles of quantitative water and electrolyte replacement of losses from osmotic diuresis.

Roumelioti ME, Ing TS, Rondon-Berrios H, Glew RH, Khitan ZJ, Sun Y, Malhotra D, Raj DS, Agaba EI, Murata GH, Shapiro JI, Tzamaloukas AH.

Int Urol Nephrol. 2018 Jul;50(7):1263-1270. doi: 10.1007/s11255-018-1822-0. Epub 2018 Mar 6. Review.

PMID:
29511980
9.

Dietary potassium and cardiovascular profile. Results from the modification of diet in renal disease dataset.

Khitan ZJ, Shweihat YR, Tzamaloukas AH, Shapiro JI.

J Clin Hypertens (Greenwich). 2018 Mar;20(3):611-612. doi: 10.1111/jch.13207. Epub 2018 Feb 19. No abstract available.

10.

Fluid balance concepts in medicine: Principles and practice.

Roumelioti ME, Glew RH, Khitan ZJ, Rondon-Berrios H, Argyropoulos CP, Malhotra D, Raj DS, Agaba EI, Rohrscheib M, Murata GH, Shapiro JI, Tzamaloukas AH.

World J Nephrol. 2018 Jan 6;7(1):1-28. doi: 10.5527/wjn.v7.i1.1. Review.

11.

Dihydropyridine calcium channel blockers in the elderly with diabetic nephropathy: Are they safe?

Khitan ZJ, Tzamaloukas AH, Brodsky S, Shapiro JI.

J Clin Hypertens (Greenwich). 2018 Jan;20(1):203-204. doi: 10.1111/jch.13158. Epub 2018 Jan 6. No abstract available.

12.

Systematic review of nephrotoxicity of drugs of abuse, 2005-2016.

Mansoor K, Kheetan M, Shahnawaz S, Shapiro AP, Patton-Tackett E, Dial L, Rankin G, Santhanam P, Tzamaloukas AH, Nadasdy T, Shapiro JI, Khitan ZJ.

BMC Nephrol. 2017 Dec 29;18(1):379. doi: 10.1186/s12882-017-0794-0. Review.

13.

Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate.

Alaini A, Malhotra D, Rondon-Berrios H, Argyropoulos CP, Khitan ZJ, Raj DSC, Rohrscheib M, Shapiro JI, Tzamaloukas AH.

World J Methodol. 2017 Sep 26;7(3):73-92. doi: 10.5662/wjm.v7.i3.73. eCollection 2017 Sep 26. Review.

14.

Reproducibility of serial creatinine excretion measurements in peritoneal dialysis.

Xu Z, Murata GH, Sun Y, Glew RH, Qualls C, Vigil D, Servilla KS, Golper TA, Tzamaloukas AH.

World J Nephrol. 2017 Jul 6;6(4):201-208. doi: 10.5527/wjn.v6.i4.201.

15.

Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.

Argyropoulos CP, Chen SS, Ng YH, Roumelioti ME, Shaffi K, Singh PP, Tzamaloukas AH.

Front Med (Lausanne). 2017 Jun 15;4:73. doi: 10.3389/fmed.2017.00073. eCollection 2017. Review.

16.

Advanced wasting in peritoneal dialysis patients.

Xu Z, Murata GH, Glew RH, Sun Y, Vigil D, Servilla KS, Tzamaloukas AH.

World J Nephrol. 2017 May 6;6(3):143-149. doi: 10.5527/wjn.v6.i3.143.

17.

Chronic Nephropathy from Dietary Hyperoxaluria: Sustained Improvement of Renal Function after Dietary Intervention.

Sun Y, Horowitz BL, Servilla KS, Fair JR, Vigil D, Ganta K, Massie L, Tzamaloukas AH.

Cureus. 2017 Mar 20;9(3):e1105. doi: 10.7759/cureus.1105.

18.

Hypertonicity: Clinical entities, manifestations and treatment.

Rondon-Berrios H, Argyropoulos C, Ing TS, Raj DS, Malhotra D, Agaba EI, Rohrscheib M, Khitan ZJ, Murata GH, Shapiro JI, Tzamaloukas AH.

World J Nephrol. 2017 Jan 6;6(1):1-13. doi: 10.5527/wjn.v6.i1.1. Review.

19.

Measuring creatinine excretion and clearance for diagnosing and staging chronic kidney disease.

Tzamaloukas AH, Malhotra D.

Int Urol Nephrol. 2017 Mar;49(3):551-552. doi: 10.1007/s11255-016-1468-8. Epub 2016 Dec 28. No abstract available.

PMID:
28032256
20.

BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection.

Vigil D, Konstantinov NK, Barry M, Harford AM, Servilla KS, Kim YH, Sun Y, Ganta K, Tzamaloukas AH.

World J Transplant. 2016 Sep 24;6(3):472-504. doi: 10.5500/wjt.v6.i3.472. Review.

21.

Osmotic Pressure in Clinical Medicine with an Emphasis on Dialysis.

Raimann JG, Tzamaloukas AH, Levin NW, Ing TS.

Semin Dial. 2017 Jan;30(1):69-79. doi: 10.1111/sdi.12537. Epub 2016 Sep 9. Review.

PMID:
27611901
22.

Hypertonicity: Pathophysiologic Concept and Experimental Studies.

Argyropoulos C, Rondon-Berrios H, Raj DS, Malhotra D, Agaba EI, Rohrscheib M, Khitan Z, Murata GH, Shapiro JI, Tzamaloukas AH.

Cureus. 2016 May 2;8(5):e596. doi: 10.7759/cureus.596. Review.

23.

Discrepancy between Measured Serum Total Carbon Dioxide Content and Bicarbonate Concentration Calculated from Arterial Blood Gases.

Kim Y, Massie L, Murata GH, Tzamaloukas AH.

Cureus. 2015 Dec 7;7(12):e398. doi: 10.7759/cureus.398.

24.

Respiratory failure in diabetic ketoacidosis.

Konstantinov NK, Rohrscheib M, Agaba EI, Dorin RI, Murata GH, Tzamaloukas AH.

World J Diabetes. 2015 Jul 25;6(8):1009-23. doi: 10.4239/wjd.v6.i8.1009. Review.

25.

Indices of serum tonicity in clinical practice.

Rohrscheib M, Rondon-Berrios H, Argyropoulos C, Glew RH, Murata GH, Tzamaloukas AH.

Am J Med Sci. 2015 Jun;349(6):537-44. doi: 10.1097/MAJ.0000000000000470.

PMID:
26002851
26.

Prolonged hypernatremia triggered by hyperglycemic hyperosmolar state with coma: A case report.

Vigil D, Ganta K, Sun Y, Dorin RI, Tzamaloukas AH, Servilla KS.

World J Nephrol. 2015 May 6;4(2):319-23. doi: 10.5527/wjn.v4.i2.319.

27.

Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms.

Konstantinov KN, Ulff-Møller CJ, Tzamaloukas AH.

Autoimmun Rev. 2015 Mar;14(3):201-3. doi: 10.1016/j.autrev.2014.10.020. Epub 2014 Nov 4. Review.

PMID:
25448042
28.

Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Glew RH, Sun Y, Horowitz BL, Konstantinov KN, Barry M, Fair JR, Massie L, Tzamaloukas AH.

World J Nephrol. 2014 Nov 6;3(4):122-42. doi: 10.5527/wjn.v3.i4.122. Review.

29.

Favorable outcome of Fournier gangrene in two patients with diabetes mellitus on continuous peritoneal dialysis.

Vigil D, Regmi A, Last R, Wiggins B, Sun Y, Servilla KS, Fair JR, Massie L, Tzamaloukas AH.

Adv Perit Dial. 2014;30:120-4.

PMID:
25338433
30.

Hyponatremia: pathophysiology, classification, manifestations and management.

Rondon-Berrios H, Agaba EI, Tzamaloukas AH.

Int Urol Nephrol. 2014 Nov;46(11):2153-65. doi: 10.1007/s11255-014-0839-2. Epub 2014 Sep 24. Review.

PMID:
25248629
31.

Management of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors?

Tzamaloukas AH, Shapiro JI, Raj DS, Murata GH, Glew RH, Malhotra D.

Am J Med Sci. 2014 Nov;348(5):432-9. doi: 10.1097/MAJ.0000000000000331. Review.

32.

Body sodium, potassium and water in peritoneal dialysis-associated hyponatremia.

Sun Y, Mills D, Ing TS, Shapiro JI, Tzamaloukas AH.

Perit Dial Int. 2014 May;34(3):253-9. doi: 10.3747/pdi.2012.00201.

33.

Respiratory Failure in the Course of Treatment of Diabetic Ketoacidosis.

Regmi A, Konstantinov NK, Agaba EI, Rohrscheib M, Dorin RI, Tzamaloukas AH.

Clin Diabetes. 2014 Jan;32(1):28-31. doi: 10.2337/diaclin.32.1.28. No abstract available.

34.

Sustained remission of antineutrophil cytoplasmic antibody-mediated glomerulonephritis and nephrotic syndrome in mixed connective tissue disease.

Konstantinov KN, Harris AA, Barry M, Murata GH, Tzamaloukas AH.

J Clin Med Res. 2013 Aug;5(4):316-21. doi: 10.4021/jocmr1391w. Epub 2013 Jun 21.

35.

Pseudomonas luteola peritonitis with favorable outcome in continuous peritoneal dialysis.

Gabaldon D, Wiggins B, Tzamaloukas AH.

Int Urol Nephrol. 2013 Dec;45(6):1827-8. doi: 10.1007/s11255-013-0492-1. Epub 2013 Jul 17. No abstract available.

PMID:
23860962
36.

Principles of management of severe hyponatremia.

Tzamaloukas AH, Malhotra D, Rosen BH, Raj DS, Murata GH, Shapiro JI.

J Am Heart Assoc. 2013 Jan 23;2(1):e005199. doi: 10.1161/JAHA.112.005199. Review. No abstract available. Erratum in: J Am Heart Assoc. 2013 Aug;2(4):e000240.

37.

Acidosis and coma in adult diabetic maintenance dialysis patients with extreme hyperglycemia.

Popli S, Sun Y, Tang HL, Kjellstrand CM, Tzamaloukas AH, Ing TS.

Int Urol Nephrol. 2013 Dec;45(6):1687-92. doi: 10.1007/s11255-013-0390-6. Epub 2013 Feb 8.

PMID:
23392961
38.

Osmotic diuresis-induced hypernatremia: better explained by solute-free water clearance or electrolyte-free water clearance?

Popli S, Tzamaloukas AH, Ing TS.

Int Urol Nephrol. 2014 Jan;46(1):207-10. doi: 10.1007/s11255-012-0353-3. Epub 2013 Jan 20.

PMID:
23334406
39.

Increase in serum creatinine in a patient on continuous peritoneal dialysis: potential mechanisms and management.

Xu Z, Gabaldon D, Wiggins B, Rondon-Berrios H, VanderJagt DJ, Tzamaloukas AH.

Adv Perit Dial. 2012;28:32-6.

PMID:
23311210
40.

The renal concentrating mechanism and the clinical consequences of its loss.

Agaba EI, Rohrscheib M, Tzamaloukas AH.

Niger Med J. 2012 Jul;53(3):109-15. doi: 10.4103/0300-1652.104376.

41.

Glomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodies.

Konstantinov KN, Emil SN, Barry M, Kellie S, Tzamaloukas AH.

ISRN Nephrol. 2013 Feb 19;2013:324315. doi: 10.5402/2013/324315. eCollection 2013. Review.

42.

Symptomatic anti-neutrophil cytoplasmic antibody-positive disease complicating subacute bacterial endocarditis: to treat or not to treat?

Konstantinov KN, Harris AA, Hartshorne MF, Tzamaloukas AH.

Case Rep Nephrol Urol. 2012 Jan;2(1):25-32. doi: 10.1159/000339409. Epub 2012 May 24.

43.

Surgical procedures before and after starting chronic hemodialysis in a predominantly male population with high prevalence of diabetes.

Martinez M, Last R, Agaba EI, Kassam H, Sun Y, Servilla KS, Murata GH, Tzamaloukas AH.

Int J Artif Organs. 2012 Sep;35(9):648-54. doi: 10.5301/ijao.5000120.

PMID:
23065894
44.

First hospitalization after kidney transplantation.

Tzamaloukas AH.

Int Urol Nephrol. 2013 Jun;45(3):921. doi: 10.1007/s11255-012-0181-5. Epub 2012 Jul 21. No abstract available.

PMID:
22821048
45.

Influence of comorbidities and inactivity on the long-term outcomes of coronary artery bypass graft surgery in a small number of men on chronic hemodialysis.

Gabaldon D, Xhu Z, Pett SB, Sun Y, Agaba EI, Servilla KS, Murata GH, Tzamaloukas AH.

Int Urol Nephrol. 2013 Feb;45(1):293-5. doi: 10.1007/s11255-012-0172-6. Epub 2012 Apr 15. No abstract available.

PMID:
22528585
46.

Development of Renal Failure without Proteinuria in a Patient with Monoclonal Gammopathy of Undetermined Significance: An Unusual Presentation of AL Kappa Amyloidosis.

Sun Y, Sandhu A, Gabaldon D, Danaraj J, Servilla KS, Tzamaloukas AH.

Case Rep Nephrol. 2012;2012:573650. doi: 10.1155/2012/573650. Epub 2012 Oct 2.

47.

Hemodialysis catheter infection with unusual presentation and grave outcome.

Gabaldon D, Xu Z, Sun Y, Servilla KS, Hartshorne MF, Tzamaloukas AH.

Hemodial Int. 2011 Oct;15(4):568-72. doi: 10.1111/j.1542-4758.2011.00584.x. Epub 2011 Aug 12.

PMID:
22111828
48.

The management of chronic kidney disease and end-stage renal disease in Nigeria.

Agaba EI, Tzamaloukas AH.

Int Urol Nephrol. 2012 Apr;44(2):653-4. doi: 10.1007/s11255-011-0004-0. Epub 2011 Jun 5. No abstract available.

PMID:
21643928
49.

Hospitalizations before and after initiation of chronic hemodialysis.

Kassam H, Sun Y, Adeniyi M, Agaba EI, Martinez M, Servilla KS, Raj DS, Murata GH, Tzamaloukas AH.

Hemodial Int. 2011 Jul;15(3):341-9. doi: 10.1111/j.1542-4758.2011.00551.x. Epub 2011 May 13.

PMID:
21564504
50.

Hospital admissions in elderly patients on chronic hemodialysis.

Sun Y, Kassam H, Adeniyi M, Martinez M, Agaba EI, Onime A, Servilla KS, Raj DS, Murata GH, Tzamaloukas AH.

Int Urol Nephrol. 2011 Dec;43(4):1229-36. doi: 10.1007/s11255-011-9913-1. Epub 2011 Mar 2.

PMID:
21360163

Supplemental Content

Loading ...
Support Center